All Pharma News
price-trendAsk Us
Affyimmune Complete Anaplastic: Thyroid Cancer Response Confirmed

Affyimmune Complete Anaplastic: Thyroid Cancer Response Confirmed
BUSINESSWIRE
23 May 2024
Share Share
AffyImmune Announces Clinical to Support Development of AIC100 in Solid Tumors

AffyImmune Announces Clinical to Support Development of AIC100 in Solid Tumors
BUSINESSWIRE
08 Apr 2024
Share Share
AffyImmune Appoints Matt Britz as CEO & Pete Gelinas as SVP of CMC

AffyImmune Appoints Matt Britz as CEO & Pete Gelinas as SVP of CMC
BUSINESSWIRE
19 Mar 2024
Share Share
AffyImmune Therapeutics to Present Poster at 2024 Annual Meeting

AffyImmune Therapeutics to Present Poster at 2024 Annual Meeting
BUSINESSWIRE
05 Mar 2024
Share Share
AffyImmune Therapeutics to Participate in a Fireside Chat

AffyImmune Therapeutics to Participate in a Fireside Chat
BUSINESSWIRE
20 Feb 2024
Share Share
AffyImmune Therapeutics Adds Robert Forrester to Board of Directors

AffyImmune Therapeutics Adds Robert Forrester to Board of Directors
PRNEWSWIRE
29 Sep 2022
Share Share
AffyImmune Therapeutics Announces Hiring of Dr. Sonal Gupta as Senior VP

AffyImmune Therapeutics Announces Hiring of Dr. Sonal Gupta as Senior VP
PRNEWSWIRE
25 Apr 2022
Share Share
AffyImmune snags $30M for `tune and track` platform for CAR-T

AffyImmune snags $30M for `tune and track` platform for CAR-T
K. LaHucik FIERCEBIOTECH
08 Oct 2021
Share Share
AffyImmune` AIC100 Granted Fast Track Designation for Treating Thyroid Cancer

AffyImmune` AIC100 Granted Fast Track Designation for Treating Thyroid Cancer
PRNEWSWIRE
17 May 2021
Share Share
AffyImmune ` AIC100 Granted Fast Track Designation for Treating Thyroid

AffyImmune ` AIC100 Granted Fast Track Designation for Treating Thyroid
PRNEWSWIRE
17 May 2021
Share Share